Category - New Drugs
FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza
Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
FDA Approves Accelerated 7-Day Vaccine Dosing Schedule for Ixiaro